Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
2010

Vancomycin Levels in Patients with Clostridium difficile Infection

Sample size: 15 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gonzales Milagros, Pepin Jacques, Frost Eric H, Carrier Julie C, Sirard Stephanie, Fortier Louis-Charles, Valiquette Louis

Primary Institution: Université de Sherbrooke

Hypothesis

To determine how faecal levels of vancomycin vary according to diarrhoea severity and dosage.

Conclusion

Faecal levels of vancomycin are proportional to the dosage administered and can be low during the first day of treatment with the standard dosage.

Supporting Evidence

  • Patients with higher stool frequency had lower faecal vancomycin levels.
  • Higher doses of vancomycin led to significantly higher faecal levels.
  • Faecal levels were consistently higher than the MIC90 of vancomycin against C. difficile.

Takeaway

This study looked at how much vancomycin gets into poop when people take it for a bad stomach bug. It found that taking more medicine means more gets into the poop.

Methodology

A prospective observational study where faeces were collected from hospitalized adults receiving different dosages of oral vancomycin.

Potential Biases

Inclusion of patients without confirmed CDI may introduce bias in the results.

Limitations

The small sample size limited the power to detect significant differences, and some patients were not confirmed to have CDI.

Participant Demographics

Median age of participants was 63 years, with 9 women and 6 men.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-10-363

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication